WBA
32
-5
BWA
50
2
GT
46
-3
PEP
27
-2
GIS
44
-3
FRT
53
2
INTU
65
-4
LLY
53
-17
VFC
47
2
SWKS
44
-9
ETR
77
2
HST
40
2
NSC
50
-4
ZBH
48
-3
NWSA
76
-2
APA
37
5
EW
41
-2
TRIP
57
2
KHC
27
-4
LB
62
7
WBA
32
-5
BWA
50
2
GT
46
-3
PEP
27
-2
GIS
44
-3
FRT
53
2
INTU
65
-4
LLY
53
-17
VFC
47
2
SWKS
44
-9
ETR
77
2
HST
40
2
NSC
50
-4
ZBH
48
-3
NWSA
76
-2
APA
37
5
EW
41
-2
TRIP
57
2
KHC
27
-4
LB
62
7
Financhill
Back

Novartis AG 10K Form

Buy
65

NVS
Novartis AG

Last Price:
$114.31
Seasonality Move:
3.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVS News And Ratings

See the #1 stock for the next 7 days that we like better than NVS

NVS Financial Statistics

Sales & Book Value

Annual Sales: $51.7B
Cash Flow: $2.2B
Price / Cash Flow: 15.11
Annual Sales: $19.58
Price / Book: 5.73

Profitability

EPS (TTM): 6.39000
Net Income (TTM): $12.9B
Gross Margin: $38.9B
Return on Equity: 30.96%
Return on Assets: 12.92%

Novartis AG Earnings Forecast

Key Novartis AG Financial Ratios

  • The Gross Profit Margin over the past 27 years for NVS is 75.20%.
  • The Selling, General & Administrative Expenses for NVS have been equal to 24.30% of Gross Profit Margin.
  • The Research & Development expenses have been 19.38% of Revenue.
  • The Interest Expense is 8.42% of Operating Income.
  • The Net Earning history of NVS is 23.09% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 17 years.

Novartis AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NVS
CUSIP: 66987V
Website: novartis.com

Debt

Debt-to-Equity Ratio: 0.77
Current Ratio: 0.79
Quick Ratio: 0.5

Price-to-Earnings

Trailing P/E Ratio: 18.97
Forward P/E Ratio: 12.35

NVS Technical Analysis vs Fundamental Analysis

Buy
65
Novartis AG (NVS) is a Buy

Is Novartis AG a Buy or a Sell?

  • Novartis AG stock is rated a Buy
    The current Novartis AG [NVS] share price is $111.33. The Score for NVS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.